The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Phenotype of asthma-chronic obstructive pulmonary disease overlap syndrome

  • Rhee, Chin Kook (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
  • Received : 2014.11.11
  • Accepted : 2014.12.03
  • Published : 2015.07.01
⟨ Previous Next ⟩

Abstract

Many patients with asthma or chronic obstructive pulmonary disease (COPD) have overlapping characteristics of both diseases. By spirometric definition, patients with both fixed airflow obstruction (AO) and bronchodilator reversibility or fixed AO and bronchial hyperresponsiveness can be considered to have asthma-COPD overlap syndrome (ACOS). However, patients regarded to have ACOS by spirometric criteria alone are heterogeneous and can be classified by phenotype. Eosinophilic inflammation, a history of allergic disease, and smoke exposure are important components in the classification of ACOS. Each phenotype has a different underlying pathophysiology, set of characteristics, and prognosis. Medical treatment for ACOS should be tailored according to phenotype. A narrower definition of ACOS that includes both spirometric and clinical criteria is needed.

Keywords

References

  1. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009;64:728-735. https://doi.org/10.1136/thx.2008.108027
  2. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998;339:1194-1200. https://doi.org/10.1056/NEJM199810223391703
  3. James AL, Palmer LJ, Kicic E, et al. Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. Am J Respir Crit C are Med 2005;171:109-114. https://doi.org/10.1164/rccm.200402-230OC
  4. Thomsen M, Nordestgaard BG, Vestbo J, Lange P. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study. Lancet Respir Med 2013;1:543-550. https://doi.org/10.1016/S2213-2600(13)70137-1
  5. Ulrik CS, Backer V. Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma. Eur Respir J 1999;14:892-896. https://doi.org/10.1034/j.1399-3003.1999.14d27.x
  6. Tai A, Tran H, Roberts M, Clarke N, Wilson J, Robertson CF. The association between childhood asthma and adult chronic obstructive pulmonary disease. Thorax 2014;69:805-810. https://doi.org/10.1136/thoraxjnl-2013-204815
  7. Covar RA, Spahn JD, Murphy JR, Szefler SJ; Childhood Asthma Management Program Research Group. Progression of asthma measured by lung function in the childhood asthma management program. Am J Respir Crit Care Med 2004;170:234-241. https://doi.org/10.1164/rccm.200308-1174OC
  8. Martinez FD, Morgan WJ, Wright AL, Holberg CJ, Taussig LM. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 1988;319:1112-1117. https://doi.org/10.1056/NEJM198810273191702
  9. Lee HY, Kang JY, Yoon HK, et al. Clinical characteristics of asthma combined with COPD feature. Yonsei Med J 2014;55:980-986. https://doi.org/10.3349/ymj.2014.55.4.980
  10. Lee JH, Haselkorn T, Borish L, Rasouliyan L, Chipps BE, Wenzel SE. Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study. Chest 2007;132:1882-1889. https://doi.org/10.1378/chest.07-0713
  11. Perret JL, Dharmage SC, Matheson MC, et al. The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age. Am J Respir Crit Care Med 2013;187:42-48. https://doi.org/10.1164/rccm.201205-0788OC
  12. Jamieson DB, Matsui EC, Belli A, et al. Effects of allergic phenotype on respiratory symptoms and exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;188:187-192. https://doi.org/10.1164/rccm.201211-2103OC
  13. Moerloose KB, Pauwels RA, Joos GF. Short-term cigarette smoke exposure enhances allergic airway inflammation in mice. Am J Respir Crit Care Med 2005;172:168-172. https://doi.org/10.1164/rccm.200409-1174OC
  14. Iwamoto H, Gao J, Koskela J, et al. Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap. Eur Respir J 2014;43:421-429. https://doi.org/10.1183/09031936.00024313
  15. Kitaguchi Y, Komatsu Y, Fujimoto K, Hanaoka M, Kubo K. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma. Int J Chron Obstruct Pulmon Dis 2012;7:283-289.
  16. Hardin M, Silverman EK, Barr RG, et al. The clinical features of the overlap between COPD and asthma. Respir Res 2011;12:127. https://doi.org/10.1186/1465-9921-12-127
  17. Menezes AM, Montes de Oca M, Perez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest 2014;145:297-304. https://doi.org/10.1378/chest.13-0622
  18. Rhee CK, Yoon HK, Yoo KH, et al. Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma. COPD 2014;11:163-170. https://doi.org/10.3109/15412555.2013.831061
  19. Diaz-Guzman E, Khosravi M, Mannino DM. Asthma, chronic obstructive pulmonary disease, and mortality in the U.S. population. COPD 2011;8:400-407. https://doi.org/10.3109/15412555.2011.611200
  20. Tashkin DP, Celli B, Decramer M, et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J 2008;31:742-750. https://doi.org/10.1183/09031936.00129607
  21. Vestbo J, Edwards LD, Scanlon PD, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 2011;365:1184-1192. https://doi.org/10.1056/NEJMoa1105482
  22. Tashkin DP, Altose MD, Connett JE, Kanner RE, Lee WW, Wise RA. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease: The Lung Health Study Research Group. Am J Respir Crit Care Med 1996;153(6 Pt 1):1802-1811. https://doi.org/10.1164/ajrccm.153.6.8665038
  23. Peters SP, Kunselman SJ, Icitovic N, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010;363:1715-1726. https://doi.org/10.1056/NEJMoa1008770
  24. Kerstjens HA, Engel M, Dahl R, et al. Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med 2012;367:1198-1207. https://doi.org/10.1056/NEJMoa1208606
  25. Iwamoto H, Yokoyama A, Shiota N, et al. Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype. Eur Respir J 2008;31:1379-1380. https://doi.org/10.1183/09031936.00014108
  26. Simpson JL, Powell H, Boyle MJ, Scott RJ, Gibson PG. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med 2008;177:148-155. https://doi.org/10.1164/rccm.200707-1134OC
  27. Brusselle GG, Vanderstichele C, Jordens P, et al. Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial. Thorax 2013;68:322-329. https://doi.org/10.1136/thoraxjnl-2012-202698
  28. Price D, Popov TA, Bjermer L, et al. Effect of montelukast for treatment of asthma in cigarette smokers. J Allergy Clin Immunol 2013;131:763-771. https://doi.org/10.1016/j.jaci.2012.12.673
  29. Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 2008;178:332-338. https://doi.org/10.1164/rccm.200712-1869OC
  30. Decramer M, Celli B, Kesten S, et al. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet 2009;374:1171-1178. https://doi.org/10.1016/S0140-6736(09)61298-8
  31. Albert RK, Connett J, Bailey WC, et al. Azithromycin for prevention of exacerbations of COPD. N Engl J Med 2011;365:689-698. https://doi.org/10.1056/NEJMoa1104623
  32. Uzun S, Djamin RS, Kluytmans JA, et al. Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med 2014;2:361-368. https://doi.org/10.1016/S2213-2600(14)70019-0
  33. Soler-Cataluna JJ, Cosio B, Izquierdo JL, et al. Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol 2012;48:331-337.

Cited by

  1. The Mechanisms of the Regulation of Immune Response in Patients with Comorbidity of Chronic Obstructive Pulmonary Disease and Asthma vol.2016, pp.None, 2015, https://doi.org/10.1155/2016/4503267
  2. Chronic bronchitis is an independently associated factor for more symptom and high-risk groups vol.11, pp.None, 2016, https://doi.org/10.2147/copd.s105516
  3. High prevalence of chronic obstructive pulmonary disease in Korea vol.31, pp.4, 2015, https://doi.org/10.3904/kjim.2016.196
  4. Factors associated with plasma IL-33 levels in patients with chronic obstructive pulmonary disease vol.12, pp.None, 2015, https://doi.org/10.2147/copd.s120445
  5. Trend of cost and utilization of COPD medication in Korea vol.12, pp.None, 2017, https://doi.org/10.2147/copd.s121687
  6. Peripheral leukocyte microRNAs as novel biomarkers for COPD vol.12, pp.None, 2017, https://doi.org/10.2147/copd.s130416
  7. Heterogeneity of asthma–COPD overlap syndrome vol.12, pp.None, 2015, https://doi.org/10.2147/copd.s130943
  8. Characterization of Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: A Qualitative Analysis vol.14, pp.3, 2015, https://doi.org/10.1080/15412555.2017.1318841
  9. Heterogeneity of asthma and COPD overlap vol.13, pp.None, 2015, https://doi.org/10.2147/copd.s152916
  10. Perceptions of Severe Asthma and Asthma-COPD Overlap Syndrome Among Specialists: A Questionnaire Survey vol.10, pp.3, 2015, https://doi.org/10.4168/aair.2018.10.3.225
  11. Is ACOS an independent nosology? Clinical signs and diagnosis of ACOS vol.28, pp.5, 2018, https://doi.org/10.18093/0869-0189-2018-28-5-519-529
  12. Longitudinal analysis to better characterize Asthma‐COPD overlap syndrome: Findings from an adult asthma cohort in Korea (COREA) vol.49, pp.5, 2015, https://doi.org/10.1111/cea.13339
  13. A comparison of diagnostic consistency for asthma-chronic obstructive pulmonary disease overlap and clinical characteristics study vol.19, pp.1, 2015, https://doi.org/10.1186/s12890-019-1024-2
  14. The Status and Influencing Factors of Respiratory System Diseases in Korean Farmers with Disease vol.31, pp.4, 2015, https://doi.org/10.7856/kjcls.2020.31.4.779